CSPG4 and neoplasm: Nevertheless, on-target/off-tumor toxicity exerted by CSPG4-CAR-T cells against pericytes and other non-malignant tissues stirs serious concerns and poses a major challenge to CSPG4-CAR-T cell therapy.